Bora Biologics: The Full-Spectrum Biologics Builders
Pharma Tech Outlook, November 2025.
Bora Biologics Named 2025 Top Microbial Development and Manufacturer
In a recent interview with Pharma Tech Outlook, CEO Stephen Lam shares insights into the company’s role as a premier Contract Development and Manufacturing Organization (CDMO). With dual hubs in San Diego and Zhubei, Bora Biologics excels in transforming biologics from early-stage research to commercial launch. Steve discusses the intricate challenges of scaling production while ensuring regulatory compliance and speed to market.
Bora Biologics combines expertise in microbial and mammalian processes, offering innovative, integrated solutions that enhance efficiency and quality.
Explore how Bora Biologics is shaping the future of biologics, empowering biotech and pharmaceutical clients to bring groundbreaking therapies to market effectively and responsibly.
